🇺🇸 FDA
Patent

US 6670374

Swainsonine compounds as inhibitors of toxin receptor expression

expired A61KA61K31/44

Quick answer

US patent 6670374 (Swainsonine compounds as inhibitors of toxin receptor expression) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/44